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Abstract 
 
This comparative study was carried out to investigate the presence of antibiotic sensitive and 
resistant bacteria in different environmental samples of Bangladesh with specific clinical strain 
obtained from ICDDR, B .The environmental samples were isolated from the month April 2014 
to September 2014 from different locations of Dhaka city to perceive the propensity of the 
environmental isolates to develop antibiotic resistance at different time periods of a year. The 
bacterial isolates were identified on the basis of standard cultural, morphological and 
biochemical characteristics. Antibiogram was done to identify the antibiotic susceptibility of the 
isolates according to CLSI guideline. The result of this study indicated that significant number of 
the environmental isolates has become resistant to the tested antibiotics, and some of them have 
become multi-resistant to these therapeutic agents whereas all the clinical isolates showed the 
opposite result. The study helps to predict the future emergence and guide the development of 
strategies to counteract this resistance. Therefore periodic and comprehensive survey of 
antibiotic resistance in the environmental bacteria is required. 
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Chapter 1: Introduction 
 
1.1 Overview 
It has long been established that, natural selection shapes the evolution of DNA based organisms, 
through the course of survival or extinction within the dynamic environment of the planet. 
Through breakthrough scientific discoveries, the all-connecting symbiotic nature of all living 
things have become more and more evident. With this knowledge it is now understood far better 
than ever that as humans, with a huge sustained footprint on the environment, we have become a 
substantial influence in the context of evolution. This idea is a bit hard to grasp as most of the 
noticeable evolution takes place over thousands to millions of years, but when it comes to 
microorganisms, it is fairly observable within human lifespan that these single celled creatures 
are adapting to the direct or indirect interactions with us and the environment as a whole, with 
ferocious rapidity. 
A growing interest among the community of microbiologists is to study this dynamic 
relationship as it is imperative to maintain our bloated life expectancy bestowed by the era of 
antibiotics. In this trend, common disease-causing microorganisms and our methods to eradicate 
or control them are subjects of repeated rigorous scientific experiments. These studies are carried 
out by various pharmaceutical companies, organizations for disease control, genetic engineers, 
biotechnologists, evolutionary microbiologists and every other group that have a vested interest 
in improving and maintain the quality of human life. 
A stark example can be the evolution of the enteric disease causing pathogens throughout 
the history of modern medicine. In the public consciousness, a disease like diarrhea has gone 
from being a sweeping epidemic that leaves us mostly helpless, to a benign inconvenience that 
we have to endure for a few days, but this underlies an uphill battle between synthetic antibiotics 
and disease causing pathogens, that microbiologists have been fighting ever since the days of 
penicillin. 
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1.2 Emerging pathogens 
A humongous number of organisms are associated with a variety of infectious diseases, and are 
considered to be human pathogens. Not only are the pre existing pathogens menacing the human 
health, but also some pathogens have only been recognized very recently. Such pathogens are 
largely accountable for a massive number of deaths every year. As many new diseases are held 
responsible for this global burden, which is taking its toll on human health, it is also true for 
diseases that had been declining over the past few years [1]. The re emergence of these diseases 
is associated with certain transmission routes and also different and wide range of hosts.  
 
1.3 Bacterial resistance to antibiotics; now and then 
Antibiotics, since its invention have been vital in the fight against infectious diseases that are 
caused by various bacteria as well as other microbes. A matter of great misery is that although 
we have all these advanced antibiotics now at our disposal, reports have shown that no antibiotic 
can actually last effective for too long. As a result, resistance in the pathogens to common 
therapeutic agents is increasing in recent years. Thus, a mere cultural contaminant or a harmless 
microbe can eventually become great human pathogen over time [2]. 
The abundance and indiscriminate use of the commercial antimicrobial drugs that are commonly 
used in the treatment of infectious diseases is the leading reason of multiple drug resistance in 
human pathogenic microorganisms that has been developed over the past years (Table 1) [5]. 
This development of antibiotic resistance has a number of favoring factors, those including the 
characteristics of the hosts, the usage of antibacterial agents, the specific nature of the 
relationship of bacteria to antibiotics, as well as environmental factors [3]. Since the bacterial 
pathogens have the ability to rapidly evolve, this helps them to come up with new ways to dodge 
the host defenses and become resistant to the antibiotic treatments. It is a matter of great concern 
that more and more pathogens are showing resistance to multiple drugs.  In addition the high 
levels of antibiotics used in humans and animals now a day have amplified the emergence of 
these antibiotic resistant strains that are the main concern of this study [4]. 
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Table 1: Profile of clinical pathogens used in this study  
Test organisms Infections Antibiotic susceptibility 
Bacillus cereus 
 
Causes food-borne illness and 
chronic skin infection, also 
causes ocular infections 
Vancomycin, Gentamycin, 
Chloramphenicol and 
Erythromycin 
Salmonella typhi 
 
Causes food poisoning and 
typhoid 
Azithromycin, Ciprofloxacin 
Shigella flexneri 
 
Causes dysentery Ampicillin, Ciprofloxacin, 
Tetracycline 
Staphylococcus aureus 
 
Causes skin and tissue 
infections 
Vancomycin 
E.coli K12 Causes urinary tract and 
wound infections, also 
problems 
after surgery 
Cephaloridine 
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1.4 Aims and objectives 
Resistance to antimicrobial agents has resulted in morbidity and mortality from treatment failures 
and increased health care costs. Even though defining the precise public health risk and estimating 
the increase in costs is not a simple undertaking, there is little doubt that emergent antibiotic 
resistance is a serious global problem. Widespread antibiotic usage exerts a selective pressure that 
acts as a driving force in the development of antibiotic resistance. 
Although pharmaceutical industries have produced a number of new antibiotics in the last few 
decades but simultaneously the resistance of the microorganisms to these drugs have also 
increased. Due to such increasing resistance in microbes and synthetic antibiotic side effects, it is 
now necessary to access resistance pattern of pathogenic organisms against standard antibiotics 
to develop therapeutic alternatives. 
 
On the basis of above context, the objectives of the present study are: 
1. The degree of antibacterial activity will be evaluated considering the diameter (mm) obtained 
for the zone of inhibition on each of the replicate agar plate. 
 
2. The resistance pattern of both clinical and environmental samples will be recorded for a 
comparative analysis. 
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Chapter 2: Materials and Methods 
 
2.1 Working laboratory 
 
All project works were performed in the Microbiology Specialized Research Laboratory, 
Department of Mathematics & Natural Sciences, BRAC University.  
 
2.2 Reference Bacterial Strains 
 
In this study, five standard clinical strain of Bacillus cereus, E. coli K12, Salmonella typhi, 
Staphylococcus aureus, and Shigella flexneri were used. All these species were obtained from 
ICDDR, B (International Center for Diarrheal Disease Research, Bangladesh).  
 
2.2.1 Preparation of plating bacteria 
 A single bacterial colony of each clinical isolates was inoculated into a screw cap test tube 
containing 5 ml Luria Bertani (LB) broth. 
 The tube was incubated at 37oC in a shaking incubator (Daihan Scientific, Korea) at 120 
rotations per min (rpm) for 3 hours. 
 After incubation 1 ml culture from the test tube was taken in an eppendorf and centrifuged 
(Eppendorf, Germany) at 12,000 rpm for 10 min and the supernatant was discarded. 
 Bacterial pellet was suspended in 1 ml of 10 mM MgSO4 properly to make it homogenous. 
 The suspension was stored at 4oC until used. 
 The suspensions were then diluted 1:100 in TSB broth to obtain 106 CFU/ml before use. 
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2.2.2 Confirmation of the reference strains 
Reference bacterial strains were identified routinely to distinguish each organism by sub 
culturing on recommended selective media (Table 2). The cultural properties of each organism 
were observed and recorded. 
 
Table 2: Respective Selective Media for Different Reference Strains 
 
Bacterial Strain Selective Media 
E .coli K12 MacConkey agar and Eosin-Methylene 
blue (EMB) agar 
Salmonella typhi Xylose Lysine Deoxycholate agar (XLD) agar 
Bacillus cereus Mannitol-Egg Yolk-Polymyxin Agar (MYP) 
Shigella flexneri Xylose  Lysine  Deoxycholate  (XLD) agar 
Staphylococcus aureus Mannitol Salt agar (MSA) 
 
2.2.3 Biochemical confirmation of the clinical strains 
Subsequently each bacterial clinical strain were employed for morphological and biochemical 
confirmation tests. Recommended biochemical tests like Methyl red test, Voges–Proskauer test, 
Indole test, Citrate utilization test, Oxidase test, Catalase test, TSI agar test were performed for 
each of the strains.  
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2.2.4 Biochemical Identification 
Biochemical tests were performed with specific standard isolates developed in specific media 
according to the standard methods described in Microbiology Laboratory Manual [6]. Before 
starting the process of any biochemical identification test, all the bacterial cultures were grown 
on nutrient agar plates in the incubator at 37
o
C.  
 
Methyl red (MR) test 
 Bacterium to be tested was inoculated into 3 ml dextrose phosphate broth (MR-VP broth), 
which contained dextrose and a phosphate buffer and incubated at 37
o
C for 24 hours. 
 Over the 24 hours, the mixed-acid producing organism might produce sufficient acid to 
overcome the phosphate buffer and remain acidic. 
 The pH of the medium was tested by the addition of five drops of MR reagent.  Development 
of a red color was taken as a positive result. MR negative organism would give a yellow 
color. 
 
Voges–Proskauer test 
 Bacterium to be tested was inoculated into 3 ml dextrose phosphate broth (MR-VP broth) and 
incubated at 37
o
C for 24 hours. 
 To the aliquots of each broth cultures 10 drops of Barritt’s reagent A was added and the 
cultures were shaken. 
 Immediately, 10 drops of Barritt’s reagent B was added and the cultures were shaken again. 
 Cultures were then kept aside for 15 minutes for the reaction to occur.  
 After 15 minutes, the colors of the cultures were examined and the results were recorded. 
Appearance of a red color was taken as a positive result. 
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Indole test 
 Bacterium to be tested was inoculated in 6 ml peptone water, which contains the amino acid 
tryptophan and incubated at 37
o
C for 24 hours. 
 Following overnight incubation, five drops of Kovac’s reagent were added. 
 Then the colors of the cultures were examined and the results were recorded. Formation of a 
rose red ring at the top indicates a positive result. A negative result can have a yellow or 
brown layer. 
 
Citrate utilization test 
 A single bacterial colony of each bacterium to be tested was picked up from each nutrient 
agar plates by a needle and inoculated into the slope of Simmon’s citrate agar and incubated 
at 37
o
C for 24 hours. 
 Over these 24 hours, the organism which had the ability to utilize citrate would change the 
color of the media. 
 All the media that changed their color from green to a Prussian blue, is taken as a positive 
result. A negative slant would have no growth of bacteria and would remain green. 
 
Triple Sugar Iron (TSI) Test 
 A single bacterial colony of each bacterium to be tested was picked up from each nutrient 
agar plates by a needle and stabbed into the TSI containing dextrose, lactose and sucrose 
butt. 
 Caps of the tubes were loosened and incubated at 35°C for overnight and were examined 
after 18-24 hours for carbohydrate fermentation, CO2 and H2S production. 
 A yellow (acidic) color in the butt indicated that the organism being tested is capable of 
fermenting all the three sugars, whereas a red (alkaline) color in the slant and butt indicated 
that the organism being tested is a non fermenter. 
 A black precipitation in the butt of the tube is the indication of H2S production. 
 Presence of bubbles, splitting and cracking of the medium is the indication of CO2 gas 
production. 
 
 Materials and Methods Page 9 
 
Oxidase test 
 
 Two drops of oxidase reagent (p- Aminodimethylaniline oxalate) were added onto the filter 
paper (Whatman, 1MM). 
 A loopful of each bacterium to be tested were taken from nutrient agar plate and streaked 
onto the filter paper (Whatman, 1MM). 
  A positive reaction would turn the paper from violet to purple within 1 to 30 seconds. 
Delayed reactions should be ignored as that might give false positive result. 
 
Catalase test 
 One drop of catalase test reagent (hydrogen peroxide) was placed on a sterile glass slide. 
 An isolate from a nutrient agar plate was picked up with a sterile toothpick and placed on to 
the reagent drop. 
 This was done with each of the bacterium to be tested. 
 An immediate bubble formation indicates a positive result. 
 
2.2.5 Preparation of Stock Sample 
 
Short term preservation 
 
3 ml of T1N1 agar butt in each vial was inoculated by stabbing isolates from nutrient agar plates. 
Then the vials were incubated at 37
o
C (SAARC) for 6 hours. After incubation, the surface of the 
medium was covered with 200 µl sterile paraffin oil and the vials were stored at room 
temperature appropriately labeled. 
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Long term preservation 
 
For long-term preservation, 500 μl of bacterial culture grown in Trypticase Soy Broth at 37oC for 
6 hours was taken in a sterile cryovial. Then 500 μl of sterile glycerol was added to the broth 
culture and the cryovial was stored at -20
o
C. 
 
2.3 Provided Antibiotic Discs 
In this study, the effectiveness of thirteen different antibiotics was determined. They are listed 
below in the table: 
 
Table 3: Provided Antibiotic Discs 
Antibiotic Disc Identification Number 
Sulfamethoxazole / Trimethoprim  (SXT 25) 
Cefoxitin  (FOX 30) 
Pefloxacin (PEF 5) 
Ciprofloxacin (CIP 5) 
Erythromycin (E 15) 
Gentamicin (CN 10) 
Kanamycin (K 30) 
Streptomycin (S 10) 
Cefuroxime  Sodium (CXM 30) 
Nalidixic Acid (NA 30) 
Oxacillin (OX 1) 
Chloramphenicol (C 30) 
Nitrofurantoin (F 300) 
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2.4 Antibiotic Susceptibility Test of the Standard Clinical Strains of Bacteria 
 
The standard clinical strains of bacteria were tested for their sensitivity against thirteen standard 
antibiotics, as mentioned previously in Table 3.  
 
2.4.1 Preparation of McFarland Solution 
 
McFarland solution is an essential material needed before testing the microorganisms for their 
sensitivity. McFarland standards are used as reference to adjust the turbidity of any given 
bacterial suspension. This is done to make sure that the number of bacteria is within a given 
range to standardize the microbial testing. This would also help avoid any error in result, because 
if the suspension is too heavy or too diluted, an erroneous result might occur for any given anti 
microbial agent, which in this study, is antibiotic discs. 
 
 97% H2SO4 was diluted to a concentration of 1% 
 BaCl2.2H2O was diluted to a concentration of 1.175% 
 To make 5 ml McFarland solution, 4975µl H2SO4 was mixed with 25µl BaCl2.2H2O. 
 
2.4.2 Preparation of inoculums 
 
 Using a sterile inoculating loop, one or two colonies of the organism to be tested   were taken 
from the subculture plate. 
 The organism was suspended in 6 ml of physiological saline. 
 The test tube containing the saline was then vortexed to create an overall smooth suspension. 
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2.4.3 Comparing with McFarland solution 
 
 Using the Colorimeter (Labtronics; ISO 9001: 2008 Certified), the OD of the McFarland 
solution was measured to be 11. 
 Then the OD of each of the inoculums that were made was also measured with the 
Colorimeter. 
 Only the solutions with the OD that matched with that of the McFarland solution were taken. 
 The solutions that gave an OD higher than the standard solution were diluted with solution to 
match the standard. 
 Once all the OD of the inoculums was matched with the standard, they were ready to be 
inoculated on MHA (Muller-Hinton Agar) plates. 
 
2.4.4 Inoculation of the MHA plates 
 
 A sterile swab was dipped into the inoculum tube. The swab was rotated against the side of 
the tube above the fluid level, using firm pressure, to remove excess fluid, but the swab was 
not dripped wet. 
 The dried surface of a MHA plate was inoculated by streaking the swab four to six times 
over the entire agar surface; the plate was rotated approximately 60 degrees each time to 
ensure an even distribution of the inoculums. 
 The plate was rimmed with the swab to pick up any excess liquid. 
 Leaving the lid slightly ajar, the plate was allowed to sit at room temperature at least 3 to 5 
minutes for the surface of the agar plate to dry before proceeding to the next step. 
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2.4.5 Placement of the Antibiotic Discs 
 
 The forceps was sterilized by immersing the forceps in alcohol then igniting. 
 Four sterile discs were placed on the surface of an agar plate, using that forceps. 
 The discs were gently pressed with the forceps to ensure complete contact with the agar 
surface. 
 Placing discs close to the edge of the plates was avoided as the zones will not be fully round 
and that can be difficult to measure. 
 Once all discs were in place, the plates were inverted, and placed in a 37°C incubator for 24 
hours. 
 
2.4.6 Measuring zone size 
 
 Following the incubation, the zone sizes were measured to the nearest millimeter using a 
ruler. 
 All measurements were made with the unaided eye while viewing the back of the Petri dish. 
 The zone size was recorded on the recording sheet. 
 
2.5 Environmental sample 
Different types of environmental samples were collected from different sources in the month of 
October, 2014 (Table 4). Throughout the month of October, the daytime temperatures had 
generally reached highs of around 30°C, which is about 86°F. At night, the average minimum 
temperature dropped down to around 21°C, which is 70°F. The average daily relative humidity 
for October was around 84%.  
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Table 4: Source of environmental samples 
 
Environmental Sample Collected from 
Chicken feces a chicken farm located at Banani 
Cow dung a farm located at Gulshan 
Handmade salad a restaurant located at Mohakhali 
Human sewage The river Buriganga 
 
2.5.1. Sample processing 
Six fold serial dilutions were done with the different environmental samples following the 
standard sample processing technique. 
 1 ml of sample suspension was taken and mixed with 9 ml of physiological saline in a test 
tube and the tube was vortexed properly to make a smooth and even suspension. 
 Then the sample was diluted six times to get the desired concentration. 
 The same procedures were followed for all four of the samples. 
 
 
2.5.2. Assortment of desired colonies from nutrient agar plates 
The maximum diluted sample was spread on nutrient agar plate for total count. Multiple colonies 
from each of the nutrient agar plates were selected depending on the cultural characteristics and 
transferred to specific standard selective media for further confirmation. 
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2.5.3 Confirmation of the organisms by biochemical tests 
Multiple selected presumptive colonies from the specific media were confirmed by biochemical 
tests following standard protocol [6], as was previously done with the reference strains. 
 
2.5.4 Antibiotic susceptibility test of the microorganisms from environmental samples 
All the steps and methods that were followed during the antibiotic susceptibility test of the 
reference bacterial strains were repeated with the microorganisms now isolated from the 
environmental samples. 
  
 
 
 
 
 
Chapter 3: Results 
  
 Results Page 16 
 
 
Chapter 3: Results 
 
3.1 Conformation of clinical strains 
Clinical strain of the five bacterial species i.e. Escherichia coli strain K12, Bacillus cereus, 
Salmonella typhi, Shigella flexneri, Staphylococcus aureus obtained from ICDDR,B 
(International Center for Diarrheal  Disease  Research, Bangladesh)  were preliminary identified 
by their cultural properties (Table 5)  upon  streaking  in  the  respective  selective  media (Table 
2). Selective medium types are formulated to support the growth of one group of organisms, but 
inhibit the growth of another. These media contain antimicrobials, dyes, or alcohol to inhibit the 
growth of the organisms that are not targeted for study. 
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Table 5: Cultural characteristics of clinical strains on respective selective media 
 
Isolates/ 
Organism 
Cultural Characteristics 
Medium Size Margin Elevation Form Pigment Consist
ency 
B. cereus MYP 
agar 
Large 
(4-5mm) 
Undulate Raised Circular Bright pink 
colonies 
with egg 
yolk 
precipitation 
Creamy
, 
smooth 
S. typhi XLD 
 
Moderat
e (2-
3mm) 
Entire Raised Convex Red 
colonies 
with  black 
centre 
Smooth 
S. 
flexneri 
XLD Moderat
e (1-
2mm) 
Entire Convex Circular Pinkish to 
reddish 
colonies 
Smooth 
S. aureus MSA Moderat
e (2-
3mm) 
Entire Convex Circular Yellow Smooth 
E. coli 
K12 
MAC Large 
(2-3mm) 
Entire Raised Circular Pink Smooth 
EMB Large 
(2-3mm) 
Entire Slightly 
raised 
Circular Blue-black 
colonies 
with 
metallic 
green sheen 
Shiny, 
smooth 
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      (a)                                                                               (b) 
 
 
    (c)                                                                               (d) 
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                                   (e)                                                                              (f)  
 
Figure 1: Cultural characteristics of clinical strains on respective selective media: 
(a) Escherichia coli K12 in MacConkey agar, 
(b) Escherichia coli K12 in Eosin Methylene blue agar, 
(c) Salmonella typhi in Xylose Lysine Deoxycholate agar, 
(d) Bacillus cereus in MYP agar, 
(e) Staphylococcus aureus in Mannitol Salt agar, 
(f) Shigella flexneri in Xylose Lysine Deoxycholate agar 
 
Isolates shown in Figure 1 showed patterns of biochemical reactions that are typical for each 
strain of bacteria according to Microbiology Laboratory Manual [6]. In Table 6 below, the results 
of biochemical tests of the clinical isolates are mentioned. 
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Table 6: Standard results of biochemical tests of target strains 
Isolate/Organism Biochemical Tests 
In
d
o
le
 p
ro
d
u
ct
io
n
 t
es
t 
M
et
h
y
l 
re
d
 r
ea
ct
io
n
 t
es
t 
V
o
g
e
s
 P
ro
s
k
a
u
e
r 
re
a
ct
io
n
 
te
st
 
C
it
ra
te
 u
ti
li
za
ti
o
n
 t
es
t 
TSI fermentation 
C
a
ta
la
se
 a
ct
iv
it
y
 t
es
t 
O
x
id
a
se
 a
ct
iv
it
y
 t
es
t 
S
la
n
t 
B
u
tt
 
C
O
2
 
H
2
S
 
Bacillus cereus - - - - A A - - + + 
Salmonella typhi - + - - K A - + + - 
Shigella flexneri - + - - K A - - + - 
Staphylococcus 
aureus 
- + - - A A + - + - 
E. coli K12 + - - + K K + - - - 
 
KEY: A= acidic condition, K= alkaline condition, + = positive, - = negative, AG= both acid & gas 
production. 
 Results Page 21 
 
 
 
   (a)                                                                              (b) 
 
 
   (c)                                                                               (d) 
 
 
 
Figure 2: IMViC test results; (a) Indole test, (b) Methyl red test, (c) Voges Proskauer test, (d) 
Citrate utilization test 
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Figure 3: Triple Sugar iron (TSI) test 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Oxidase Test 
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Figure 5: Catalase test 
 
 
3.2 Confirmation of the environmental strains by biochemical tests 
Desired presumptive environmental strains of Escherichia coli strain K12, Bacillus cereus, 
Salmonella typhi, Shigella flexneri, and Staphylococcus aureus are selected from specific media 
(Table 2) depending on their cultural characteristics (Table 7). 
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Table 7: Cultural characteristics of the environmental strains 
 
Isolates/ 
Organisms 
Cultural Characteristics 
Medium Size Margin Elevation Form Pigment Consisten
cy 
Bac 1 MYP agar Large 
(4-
5mm) 
Undulat
e 
Raised Circular Bright 
pink 
colonies 
with egg 
yolk 
precipitat
ion 
Creamy, 
smooth 
Bac 2 MYP agar Modera
te (1-
2mm) 
Entire Convex Irregula
r 
Colorless Smooth 
Bac 3 MYP agar Modera
te (2-
3mm) 
Entire Flat Convex Pinkish Smooth 
Bac 4 MYP agar Large 
(2-
3mm) 
Entire Slightly 
Raised 
Irregula
r 
Yellowis
h 
Smooth 
Sal 1 XLD Modera
te (2-
3mm) 
Entire Convex Circular Colorless Creamy 
Sal 2 XLD Small 
(1-
2mm) 
Entire Convex Circular Pinkish Smooth 
Sal 3 XLD 
 
Modera
te (2-
Entire Raised Convex Red 
colonies 
Smooth 
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3mm) with  
black 
centre 
Sal 4 XLD Large 
(2-
3mm) 
Undulat
e 
Slightly 
raised 
Irregula
r 
Colorless Smooth 
Shi 1 XLD Modera
te (2-
3mm) 
Entire Raised Convex Pink Smooth 
Shi 2 XLD Large 
(2-
3mm) 
Entire Raised Irregula
r 
Colorless Smooth 
Shi 3 XLD Modera
te (1-
2mm) 
Entire Convex Circular Pinkish 
to reddish 
colonies 
Smooth 
Shi 4 XLD Small 
(1-
2mm) 
Entire Slightly 
raised 
Circular Colorless Creamy 
Sta 1 MSA Modera
te (2-
3mm) 
Entire Raised Circular Yellowis
h 
Smooth 
Sta 2 MSA Modera
te (2-
3mm) 
Entire Convex Circular Yellow Smooth 
Sta 3 MSA Large 
(2-
3mm) 
Entire Slightly 
raised 
Ireregul
ar 
Colorless Creamy 
Sta 4 MSA Small 
(1-
2mm) 
Entire Convex Circular Colorless Smooth 
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Esc 1 MAC Small 
(1-
2mm) 
Entire Flat Circular Pink Rough 
EMB Modera
te (2-
3mm) 
Entire Flat Circular Pink Smooth 
Esc 2 MAC Small 
(1-
2mm) 
Entire Raised Circular Purple Smooth 
EMB Small 
(1-
2mm) 
Entire Raised Circular Pink Smooth 
Esc 3 MAC Small 
(1-
2mm) 
Entire Slightly 
raised 
Circular Slight 
Pink 
Rough 
EMB Modera
te (2-
3mm) 
Entire Flat Circular Colorless Smooth 
Esc 4 MAC Large 
(2-
3mm) 
Entire Raised Circular Pink Smooth 
EMB Large 
(2-
3mm) 
Entire Slightly 
raised 
Circular Blue-
black 
colonies 
with 
metallic 
green 
sheen 
Shiny, 
smooth 
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A total of twenty colonies belonging to five target strains isolated from different environmental 
sources (Table 4) were selected depending on the presumptive cultural characteristics which 
were further confirmed by standard biochemical tests showed below in Table 8. 
 
Table 8: Biochemical test results of the environmental strains 
 
Isolate/Organism Biochemical Tests 
In
d
o
le
 p
ro
d
u
ct
io
n
 t
es
t 
M
et
h
y
l 
re
d
 r
ea
ct
io
n
 t
es
t 
V
o
g
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 P
ro
sk
a
u
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 r
ea
ct
io
n
 t
es
t 
C
it
ra
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ti
o
n
 t
es
t 
TSI fermentation 
C
a
ta
la
se
 a
ct
iv
it
y
 t
es
t 
O
x
id
a
se
 a
ct
iv
it
y
 t
es
t 
S
la
n
t 
B
u
tt
 
C
O
2
 
H
2
S
 
Bac 1 - - - - A A - - + + 
Bac 2 - _ - + K K + - - - 
Bac 3 + - - - K K - + - + 
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Bac 4 + + - - A K + - + - 
Sal 1 - + - - A A + - + + 
Sal 2 - - + - K A + - + - 
Sal 3 - + - - K A - + + - 
Sal 4 + + - - A K - - - + 
Shi 1 + - + + K K + - - - 
Shi 2 - - + + K A - + + - 
Shi 3 - + - - K A - - + - 
Shi 4 + - - - K A - + - + 
Sta 1 + - + - A K + + + + 
Sta 2 - + - - A A + - + - 
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Sta 3 - - + - A K + - + - 
Sta 4 - - + - K K - - + - 
Esc 1 + - - + K K + - - - 
Esc 2 - + - - K A - - + - 
Esc 3 - - - + K A + - + - 
Esc 4 + - - + K K + - - - 
 
According to Table 7 and 8, Bac 1, Sal 3, Shi 3, Sta 2, and Esc 4 showed standard cultural 
characteristics as well as standard biochemical test results following Table 5 and 6, hence they 
were selected for further studies. 
 
3.3 Selective antimicrobial activity test by means of antibiogram method 
The standard disc diffusion test was done with all the provided antibiotics (Table 3) against five 
clinical and isolates of five selected environmental strains to identify their resistance pattern. The 
interpretive categories were defined according to the zone diameter of inhibition. 
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All the clinical strains showed significant susceptibility to all the antibiotics except for OX1 
(Table 9).  Salmonella typhi showed the maximum level of susceptibility to C30, which was 
around 34mm in diameter, whereas, both E. coli K12 and Bacillus cereus showed highest levels 
of susceptibility to CIP5 which was measured to be 40mm and 28mm in diameter respectively. 
Bacillus cereus also showed the similar level of susceptibility (28mm in diameter) to E15 as 
well.  In case of Shigella flexneri, the utmost level of susceptibility was observed when CXM30 
and FOX30 were applied in the disc diffusion test (26mm in diameter). In case of 
Staphylococcus aureus, the maximal level of vulnerability was to PEF5, which was around 
32mm in diameter. Antibiotic susceptibility test results for clinical strains are represented in 
Table 9 and Figures 6, 7, 8, 9, and 10 below. 
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Table 9: Antibiotic susceptibility test results for clinical strains 
 
Antibiotics Clinical Strains 
S. typhi E. coli K12 B. cereus S. flexneri S. aureus 
SXT 25 33 mm 30 mm 9 mm 0 mm 28 mm 
FOX 30 32 mm 28 mm 24 mm 26 mm 30 mm 
PEF 5 22 mm 32 mm 25 mm 0 mm 32 mm 
CIP 5 27 mm 40 mm 28 mm 16 mm 28 mm 
E 15 8 mm 9 mm 28 mm 20 mm 9 mm 
CN 10 25 mm 20 mm 25 mm 22 mm 20 mm 
K 30 25 mm 19 mm 24 mm 24 mm 20 mm 
S 10 17 mm 14 mm 20 mm 0 mm 14 mm 
CXM 30 26 mm 25 mm 0 mm 26 mm 26 mm 
NA 30 0 mm 24 mm 0 mm 0 mm 25 mm 
OX 1 0 mm 0 mm 0 mm 0 mm 0 mm 
C 30 34 mm 24 mm 26 mm 16 mm 26 mm 
F 300 23 mm 26 mm 22 mm 24 mm 24 mm 
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(a) 
 
(b) 
Figure 6: (a) and (b) Effect of provided antibiotics on clinical strain of B. cereus 
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(a) 
 
(b) 
Figure 7: (a) and (b) Outcome of given antibiotics on clinical strain of E. coli K12 
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(a) 
 
(b) 
Figure 8: (a) and (b) Susceptibility pattern of supplied antibiotics on clinical strain of S. aureus 
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(a) 
 
(b) 
Figure 9: (a) and (b) Effect of provided antibiotics on clinical strain of S. flexneri 
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(a) 
 
(b) 
Figure 10: (a) and (b) Effectiveness of the applied antibiotics on clinical strain of S. typhi 
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A significant level of resistance was observed when all the standard antibiotics were applied 
against several isolates of selected environmental strains that were Bacillus cereus collected from 
salad sample and human sewage sample, Shigella flexneri collected from chicken feces, and 
Salmonella typhi collected from human sewage sample. E. coli was collected from salad sample 
and bovine sample (cow dung), and Staphylococcus aureus was collected from human sewage 
sample and chicken feces. They all showed resistance to at least one or more than one antibiotics. 
In case of B. cereus collected from salad sample, the isolate S3 showed resistance to the 
antibiotic FOX30, and the isolate S6 was resistant to PEF5 and F300, whereas, the clinical strain 
of B. cereus showed significant zone of inhibition to these same antibiotics, which were 
measured to be 24mm, 25mm and 22mm in diameter respectively (Table 10). The isolate H1 of 
B. cereus collected from human sewage sample showed resistance to the antibiotic PEF5 and H2 
showed resistance to CIP5 and S10. On the other hand their clinical strain showed zone of 
inhibition to these same antibiotics which were 25mm, 28mm, and 20mm in diameter 
respectively (Table 11). 
The isolate C3 of S. flexneri collected from chicken feces showed resistance against two different 
antibiotics, FOX30 and E15, whereas the susceptibility of their clinical strain to these antibiotics 
was 26mm and 20mm in diameter respectively (Table 12). In case of S. typhi, which was 
collected from human sewage sample, the isolate H1 showed resistance to the antibiotics  
FOX30, E15, and S10, and the isolate H3 showed resistance to the antibiotics SXT25, PEF5, 
E15, and C30. The clinical strain of S. typhi was vulnerable to all these antibiotics (Table 13). 
The clinical strain of E. coli was significantly vulnerable to all the antibiotics, yet three different 
isolates of E. coli collected from salad sample showed resistance to three different antibiotics 
each (Table 14) and four isolates collected from the bovine sample (cow dung) showed 
resistance to three and four different antibiotics each (Table 15 ). 
In case of environmental strain of Staphylococcus aureus, the result was astounding. Its clinical 
strain was susceptible to all the test antibiotics but one, having large zones of inhibition 
measured to be as high as 28-32mm in diameter and yet different isolates of S. aureus collected 
from human sewage sample (Table 16) and chicken feces (Table 17) showed resistance to as 
many as four and eight different antibiotics as shown below. 
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Table 10:  Antibiotic susceptibility test results for B. cereus collected from salad sample 
Antibiotics B. cereus From Salad Sample 
B. cereus 
S1 
B. cereus 
S2 
B. cereus 
S3 
B. cereus 
S4 
B. cereus 
S5 
B. cereus 
S6 
SXT 25 26 mm 8 mm 10 mm 14 mm 11 mm 17 mm 
FOX 30 23 mm 18 mm Resistant 9 mm 16 mm 26 mm 
PEF 5 14 mm 20 mm 15 mm 18 mm 21 mm Resistant 
CIP 5 17 mm 12 mm 13 mm 17 mm 20 mm 18 mm 
E15 15 mm 20 mm 11 mm 24 mm 7 mm 22 mm 
CN 10 24 mm 23 mm 17 mm 11 mm 14 mm 20 mm 
K 30 20 mm 28 mm 18 mm 24 mm 24 mm 19 mm 
S 10 20 mm 18 mm 18 mm 21 mm 10 mm 16 mm 
CXM 30 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 
NA 30 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 
OX 1 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 
C 30 23 mm 19 mm 15 mm 28 mm 31 mm 24 mm 
F 300 
 
18  mm 9 mm 16 mm 13 mm 7 mm Resistant 
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Table 11:  Antibiotic susceptibility test results for B. cereus collected from human sewage 
sample 
Antibiotics B. cereus From Human Sewage Sample 
B. cereus 
H1 
B. cereus 
H2 
B. cereus 
H3 
B. cereus 
H4 
B. cereus 
H5 
B. cereus 
H6 
SXT 25 9 mm 11 mm 7 mm 18 mm 21 mm 13 mm 
FOX 30 11 mm 9 mm 5 mm 7 mm 10 mm 16 mm 
PEF 5 Resistant 13 mm 10 mm 14 mm 17 mm 22 mm 
CIP 5 19 mm Resistant 16 mm 24 mm 21 mm 20 mm 
E15 14 mm 19 mm 15 mm 21 mm 11 mm 20 mm 
CN 10 9 mm 22 mm 12 mm 18 mm 26 mm 14 mm 
K 30 18 mm 17 mm 20 mm 18 mm 18 mm 18 mm 
S 10 21 mm Resistant 23 mm 26 mm 20 mm 24 mm 
CXM 30 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 
NA 30 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 
OX 1 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 
C 30 16 mm 14 mm 13 mm 7 mm 10 mm 8 mm 
F 300 
 
12 mm 11 mm 14 mm 
 
20 mm 13 mm 17 mm 
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Table 12:  Antibiotic susceptibility test results for S. flexneri collected from chicken feces 
Antibiotics S. flexneri From Chicken Feces 
S. 
flexneri 
C1 
S. 
flexneri 
C2 
S. 
flexneri 
C3 
S. 
flexneri 
C4 
S. 
flexneri 
C5 
S. 
flexneri 
C6 
S. 
flexneri 
C7 
SXT 25 15 mm 12 mm 0 mm 21 mm 17 mm 19 mm 14 mm 
FOX 30 24 mm 19 mm Resistant 16 mm 20 mm 18 mm 12 mm 
PEF 5 20 mm 16 mm 8 mm 22 mm 22 mm 14 mm 19 mm 
CIP 5 17 mm 19 mm 12 mm 25 mm 21 mm 31 mm 24 mm 
E15 22 mm 11 mm Resistant 15 mm 19 mm 23 mm 15 mm 
CN 10 22 mm 13 mm 9 mm 18 mm 21 mm 19 mm 13 mm 
K 30 23 mm 16 mm 21 mm 32 mm 24 mm 21 mm 17 mm 
S 10 26 mm 11 mm 8 mm 13 mm 17 mm 17 mm 19 mm 
CXM 30 20 mm 20 mm 23 mm 20 mm 27 mm 24 mm 22 mm 
NA 30 19  mm 17 mm 0 mm 13 mm 30 mm 11 mm 16 mm 
OX 1 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 
C 30 17 mm 19 mm 9 mm 14 mm 16 mm 11 mm 7 mm 
F 300 
 
25 mm 11 mm 10 mm 6 mm 11 mm 28 mm 22 mm 
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Table 13:  Antibiotic susceptibility test results for S. typhi collected from human sewage 
sample 
Antibiotics S. typhi From Human sewage sample 
S. typhi 
H1 
S. typhi 
H2 
S. typhi 
H3 
S. typhi 
H4 
S. typhi 
H5 
S. typhi 
H6 
SXT 25 18 mm 16 mm Resistant 19 mm 15 mm 13 mm 
FOX 30 Resistant 21 mm 12 mm 17 mm 23 mm 21 mm 
PEF 5 26 mm 18 mm Resistant 22 mm 20 mm 21 mm 
CIP 5 23 mm 22 mm 13 mm 20 mm 19 mm 17 mm 
E15 Resistant 11 mm Resistant 9 mm 13 mm 13 mm 
CN 10 13 mm 17 mm 15 mm 19 mm 17 mm 15 mm 
K 30 17 mm 9 mm 10 mm 15 mm 13 mm 7 mm 
S 10 Resistant 11 mm 16 mm 12 mm 11 mm 14 mm 
CXM 30 22 mm 23 mm 16 mm 11 mm 28 mm 21 mm 
NA 30 29 mm 21 mm 0 mm 19 mm 22 mm 17 mm 
OX 1 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 
C 30 14 mm 11 mm Resistant 11 mm 14 mm 12 mm 
F 300 
 
11 mm 11 mm 9 mm 7 mm 12 mm 8 mm 
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Table 14:  Antibiotic susceptibility test results for E. coli collected from salad sample 
Antibio
tics 
E. coli From Salad Sample 
E. coli 
S1 
E. coli 
S2 
E. coli 
S3 
E. coli 
S4 
E. coli 
S5 
E. coli 
S6 
E. coli 
S7 
E. coli 
S8 
E. coli 
S9 
SXT 25 8 mm 12 mm Resista
nt 
14 mm 14 mm 10 mm 12 mm 19 mm 12 mm 
FOX 30 6 mm 19 mm 8 mm 16 mm 19 mm 12 mm 17 mm 21 mm 13 mm 
PEF 5 Resista
nt 
13 mm 12 mm 15 mm 22 mm 12 mm 14 mm 12 mm 28 mm 
CIP 5 20 mm 24 mm 28 mm 24 mm 18 mm 21 mm 19 mm 20 mm 22 mm 
E15 18 mm 14 mm 9 mm 14 mm 21 mm 10 mm 11 mm 13 mm Resista
nt 
CN 10 Resista
nt 
10 mm 8 mm 14 mm 19 mm 17 mm 13 mm 18 mm 17 mm 
K 30 14 mm 18 mm Resista
nt 
22 mm 22 mm 27 mm 24 mm 22 mm Resista
nt 
S 10 22 mm 24 mm 13 mm 19 mm 15 mm 28 mm 24 mm 20 mm 21 mm 
CXM 
30 
Resista
nt 
18 mm Resista
nt 
17 mm 11 mm 14 mm 28 mm 19 mm 15 mm 
NA 30 10 mm 13 mm 6 mm 11 mm 9 mm 8 mm 18 mm 15 mm 9 mm 
OX 1 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 
C 30 13 mm 9 mm 10 mm 13 mm 15 mm 18 mm 19 mm 8 mm 14 mm 
F 300 
 
16  
mm 
14 mm 13 mm 19 mm 11 mm 15 mm 13 mm 11 mm 12 mm 
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Table 15:  Antibiotic susceptibility test results for E. coli collected from bovine sample 
Antibi
otics 
 E. coli From Bovine Sample 
E. coli 
B1 
E. coli 
B2 
E. coli 
B3 
E. coli 
B4 
E. coli 
B5 
E. coli 
B6 
E. coli 
B7 
E. coli 
B8 
E. coli 
B9 
SXT 
25 
7 mm 12 mm Resista
nt 
16 mm Resista
nt 
18 mm 12 mm 10 mm 14 mm 
FOX 
30 
5 mm 9 mm 12 mm 16 mm 8 mm 11 mm 16 mm 14 mm 17 mm 
PEF 5 Resista
nt 
15 mm Resista
nt 
17 mm 12 mm 10mm 19 mm 14 mm 12 mm 
CIP 5 16 mm 13 mm 8 mm 10 mm 28 mm 23 mm 10 mm 8 mm 14 mm 
E15 Resista
nt 
19 mm 9 mm 11 mm 9 mm 10 mm 17 mm Resista
nt 
12 mm 
CN 10 12 mm 12 mm 15 mm 11 mm 8 mm 15 mm 18 mm Resista
nt 
14 mm 
K 30 20 mm 18 mm 18 mm 10 mm Resista
nt 
22 mm 11 mm 16 mm 19 mm 
S 10 Resista
nt 
18 mm 13 mm 17 mm 13 mm 24 mm 11 mm 20 mm 16 mm 
CXM 
30 
0 mm 13 mm 16 mm 16 mm 20 mm 22 mm 19 mm Resista
nt 
14 mm 
NA 30 0 mm 0 mm Resista
nt 
0 mm 6 mm 9 mm 8 mm 10 mm 17 mm 
OX 1 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 
C 30 13 mm 15 mm 16 mm 9 mm 10 mm 22 mm 24 mm Resista
nt 
20 mm 
F 300 
 
20 mm 16 mm 14 mm 19 mm 13 mm 17 mm 20 mm 21 mm 18 mm 
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Table 16:  Antibiotic susceptibility test results for S. aureus collected from human sewage 
sample 
Antibioti
cs 
S. aureus From Human sewage sample 
S. 
aureus 
H1 
S. 
aureus 
H2 
S. 
aureus 
H3 
S. 
aureus 
H4 
S. 
aureus 
H5 
S. 
aureus 
H6 
S. 
aureus 
H7 
S. aureus 
H8 
SXT 25 18 mm 22 mm 12 mm 18 mm 17 mm 14 mm 18 mm 21 mm 
FOX 30 17 mm 19 mm 14 mm 26 mm 21 mm 18 mm 28 mm 33 mm 
PEF 5 24 mm 26 mm 8 mm 13 mm 17 mm 11 mm 15 mm 29 mm 
CIP 5 11 mm 16 mm 6 mm 18 mm 21 mm 13 mm 13 mm 25 mm 
E15 16 mm 11 mm 7 mm 22 mm Resista
nt 
8 mm 11 mm 11 mm 
CN 10 21 mm 13 mm 5 mm 17 mm Resista
nt 
6 mm 13 mm Resistant 
K 30 19 mm 11 mm 11 mm 13 mm 19 mm 22 mm 12 mm 20 mm 
S 10 24 mm 23 mm 11 mm 16 mm 22 mm 15 mm 28 mm 31 mm 
CXM 30 20 mm 21 mm 15 mm 19 mm 26 mm 11 mm 24 mm Resistant 
NA 30 26 mm 21 mm Resista
nt 
13 mm Resista
nt 
9 mm 19 mm 17 mm 
OX 1 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 
C 30 19 mm 13 mm 28 mm 25 mm 11 mm 7 mm 18 mm 18 mm 
F 300 
 
11 mm 9 mm 23 mm 13 mm Resista
nt 
5 mm 17 mm 22 mm 
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Table 17:  Antibiotic susceptibility test results for S. aureus collected from chicken feces 
Antibiotics S. aureus From Chicken Feces 
S. 
aureus 
C1 
S. 
aureus 
C2 
S. 
aureus 
C3 
S. 
aureus 
C4 
S. 
aureus 
C5 
S. 
aureus 
C6 
S. 
aureus 
C7 
S. 
aureus 
C8 
SXT 25 9 mm 11 mm Resistant 17 mm 21 mm 19 mm 15 mm 22 mm 
FOX 30 13 mm 17 mm 12 mm 16 mm 11 mm 25 mm 19 mm 11 mm 
PEF 5 11 mm 9 mm Resistant 28 mm Resistant 17 mm 15 mm 26 mm 
CIP 5 14 mm 11 mm Resistant 19 mm Resistant 15 mm 13 mm 15 mm 
E15 13 mm 15 mm Resistant 22 mm 12 mm 18 mm 11 mm 17 mm 
CN 10 12 mm 18 mm Resistant 10 mm 8 mm 14 mm 17 mm 15 mm 
K 30 28 mm 13 mm Resistant 7 mm 19 mm 21 mm 15 mm 13 mm 
S 10 24 mm 16 mm Resistant 24 mm 22 mm 19 mm 21 mm 11 mm 
CXM 30 21 mm 19 mm 21 mm 26 mm 23 mm 21 mm 23 mm 17 mm 
NA 30 28 mm 26 mm Resistant 13 mm 17 mm 15 mm 19 mm 24 mm 
OX 1 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 0 mm 
C 30 19 mm 16 mm 28 mm 21 mm 31 mm 33 mm 22 mm 25 mm 
F 300 
 
14 mm 22 mm 21 mm 11 mm 16 mm 19 mm 17 mm 19 mm 
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(a) 
 
(b) 
Figure 11: (a) and (b) Effect of provided antibiotics on B. cereus S3 isolate collected from salad 
sample 
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(a) 
 
(b) 
Figure 12: (a) and (b) Effect of provided antibiotics on B. cereus H2 isolate collected from 
human sewage sample 
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(a) 
 
(b) 
Figure 13: (a) and (b) Effectiveness of applied antibiotics on S. typhi H3 isolate collected from 
human sewage sample 
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(a) 
 
(b) 
Figure 14: (a) and (b) Effect of provided antibiotics on S. flexneri C3 isolate collected from 
chicken feces 
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(a) 
 
(b) 
Figure 15: (a) and (b) Outcome of given antibiotics on E. coli B3 isolate collected from bovine 
sample 
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(a) 
 
(b) 
Figure 16: (a) and (b) Outcome of given antibiotics on E. coli S3 isolate collected from salad 
sample 
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(a) 
 
(b) 
Figure 17: (a) and (b) Effectiveness of applied antibiotics on S. aureus C3 isolate collected from 
chicken feces 
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(a) 
 
(b) 
Figure 18: (a) and (b) Effectiveness of applied antibiotics on S. aureus H3 isolate collected from 
human sewage sample 
 Results Page 54 
 
3.4 Comparative analysis of antibiotic susceptibility profiles of clinical and environmental 
strains 
A comparative study was carried out among clinical and environmental samples isolated from 
salad sample, human sewage sample, chicken feces, and bovine sample. Results indicate strong 
differences in the numbers of different environmental isolates and the clinical strains in terms of 
the development of resistance to standard antibiotic disc. 
B. cereus isolates collected from salad sample showed resistance to the antibiotic FOX30, PEF5 
and F300 whereas B. cereus collected from human sewage sample showed resistance to PEF5, 
CIP5, and S10 when compared to clinical isolates of B. cereus for the same antimicrobial tested. 
S. flexneri isolate collected from the feces of chicken showed resistance against two different 
antibiotics, FOX30 and E15, whereas for their clinical strains, its susceptibility to these 
antibiotics were moderately high. E. coli isolates collected from salad sample and bovine sample 
both showed resistance to two-three different antibiotics each. On the other hand, the clinical 
strain of E. coli was considerably vulnerable to those same antibiotics. A noticeable fact in the 
susceptibility test result of S. typhi was that its clinical strain showed maximum level of 
susceptibility to the antibiotic C30, according to section 3.3, and one of its environmental isolate 
namely H3 collected from human sewage sample showed resistance to this same antibiotic. In 
case of Staphylococcus aureus, its clinical strain was susceptible to all the antibiotics but one, 
and yet its environmental isolates collected both from human sewage sample and chicken feces 
showed resistance to as many as four and eight different antibiotics as presented in the figures 
below. 
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Figure 19: Comparison among the efficiency of different antibiotics on clinical and 
environmental samples of B. cereus spp collected from salad sample 
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Figure 20: Comparison among the efficiency of different standard antibiotics on clinical and 
environmental samples of B. cereus spp collected from human sewage sample 
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Figure 21: Comparative analysis of the effect of different antibiotics on clinical and 
environmental Salmonella typhi spp collected from human sewage sample 
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Figure 22: Comparative analysis of the effect of different antibiotics on clinical and 
environmental Shigella flexneri spp collected from chicken feces 
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Figure 23: Comparison among the efficiency of different antibiotics on clinical and 
environmental samples of E. coli spp collected from bovine sample 
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Figure 24: Comparison among the efficiency of different antibiotics on clinical and 
environmental samples of E. coli spp collected from salad sample 
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Figure 25: Comparison among the efficiency of different antibiotics on clinical and 
environmental samples of Staphylococcus aureus spp collected from chicken feces 
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Figure 26: Comparison among the efficiency of different antibiotics on clinical and 
environmental samples of Staphylococcus aureus spp collected from human sewage sample
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Chapter 4: Discussion 
 
Antibiotic resistance is the ability of bacteria to endure the antimicrobial activity of antibiotics. It 
is now apparent that antibiotics that are used to alleviate an infection do not always work 
anymore. Antibiotic resistance is a global issue, and The US Centers for Disease Control and 
Prevention (CDC) considers antibiotic resistance one of their peak concerns [7]. 
One of the greatest discoveries of the 20th century is undoubtedly the finding of 
antibiotics. This fact is evident, but the genuine speculation is the rise of antibiotic resistance in 
hospitals, communities, and the environment is associated with their use. The surprising yet 
alarming new genetic capacities of microorganisms have facilitated from man's overuse of 
antibiotics to exploit every source of their resistance genes and every means of horizontal gene 
transmission to develop multi-resistant strains [8]. Such has been seen in this study, that the 
clinical strain of Staphylococcus aureus was significantly vulnerable to the antibiotics, yet the 
same strain isolated from the feces of chicken showed resistance to as many as eight different 
antibiotics. This is surely something to be concerned about.  
Even prior to penicillin was introduced, resistant strains of bacteria had been detected. 
The selection pressure has been caused by the exercise of millions of antibiotics over the past 75 
years. Ever since antibiotics were introduced to mankind, the abundant use of antibiotics has 
made almost all disease-causing bacteria resistant to the antibiotics that are commonly used to 
treat them [7]. 
Our environment contains numerous products that are man-made or triggered by human 
contamination, a large variety of examples can be petroleum chemicals, chemical solvents, the 
products and waste of industrial processes, heavy metals, garbage, and so on. Since the early 
development of the industrial revolution, humankind has dumped ever-growing amounts of 
organic and inorganic toxins into streams, rivers, seas, oceans, land, and as well as air. Before the 
discovery of antibiotics, arsenic, mercury, and iodine were used industrially and, as medicinal. 
Which under some circumstances, are still employed as such. The major bacterial solution to 
toxic challenges has taken the form of multivalent pumping systems that prevent intracellular 
accumulation of structurally diverse bactericidal and bacteriostatic substances [9]. 
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Antimicrobial resistance is a global problem. Although antimicrobial agents have played 
a major role in reducing the threat from communicable diseases, but the widespread use of these 
synthetic agents has increasingly resulted in the development of microorganisms that are 
resistant. In recent years, resistance to these agents has been recognized as a major threat to 
public health. Emergence of multidrug resistance has limited the therapeutic options, so 
monitoring the resistance pattern has vital importance [10]. Resistance has increasingly become 
an even bigger problem in recent years due to the drastically slowed pace at which novel 
antibiotics are being discovered, while antibiotic use is rising rapidly [11]. This study presents 
the most important aspects of antibiotic resistance development through a longitudinal study, 
with the conclusion that it is time to take action. To achieve complete reimbursement of 
therapeutic applications of antibiotics, we need to gather more information on the rise of 
antibiotic resistance. Creative approaches to the discovery of novel antibiotics and their 
accelerated and controlled introduction to therapy are mandatory, given the recent situation of 
antimicrobial resistance [12]. 
The environmental strains of Bacillus cereus, Staphylococcus aureus, Salmonella typhi, 
Shigella flexneri and Escherichia coli are isolated from different potential environmental sources 
like salad sample, sewage water, chicken feces, bovine sample etc. Target environmental 
bacterial species were identified and used for the identification of antibiotic resistance pattern in 
compare to clinical strains obtained from ICDDR,B (International Center for Diarrheal Disease 
Research, Bangladesh). All strains were confirmed by means of specific biochemical tests and 
confirmed in selective media and maintained in nutrient ager medium.  
B. cereus was isolated from two different environmental sample for this study, which are, 
human sewage sample and salad sample. Isolates from both samples showed much less 
resistance pattern than the other test organisms. B. cereus S3 collected from salad sample showed 
resistance to FOX 30 and B. cereus S6 showed resistance to PEF5, and F 300 (Figure 11). 
Whereas, the other isolates from salad sample showed no resistance to any of the test antibiotics. 
On the other hand, B. cereus H1 isolated from human sewage sample was observed to be 
resistant to PEF5 and B. cereus H2 was resistant to CIP5 and S10. No other B. cereus isolated 
from human sewage sample was resistant to any antibiotics (Figure 12). 
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In this study, two different isolates of S. typhi showed resistance to different antibiotics. 
For human sewage sample isolates, S. typhi H1 showed resistance to FOX 30, E15, and S10. 
Additionally, S. typhi H3 was resistant to SXT25, PEF5, E15, and C30. No other S. typhi isolates 
showed any resistance pattern (Figure 13). The isolates of S. flexneri collected from chicken 
feces showed very little resistance pattern. The isolate S. flexneri C3 was resistant to FOX30, and 
E15. No other S. flexneri isolates were observed to be resistant to any of the tested antibiotics 
(Figure 14).  
E. coli was also isolated from two different sources for this study, bovine and salad 
sample. Isolates from both sample showed astounding resistance pattern. Among the isolates 
from bovine sample, E. coli B1 was resistant to PEF5, E15, and S10, E. coli B3 was resistant to 
SXT25, PEF5, and NA30. E. coli B5 was resistant to SXT25, and K30. E. coli B8 was observed 
to be resistant to four different antibiotics, which are E15, CN10, CXM30, and C30. All the other 
isolates from bovine sample showed resistance to none of the tested antibiotics (Figure 15). E. 
coli isolates from salad sample also showed great resistance pattern. E. coli S1 was resistant to 
PEF5, CN10, and CXM30, E. coli S3 was resistant to SXT25, and K30, and CXM30. E. coli S9 
showed resistance to E15, and K 30. However, no other E. coli isolates from salad sample was 
resistant to any of the test antibiotics (Figure 16). 
From chicken feces and human sewage sample, S. aureus was isolated. Isolates from both 
sample showed astonishing resistance pattern. Among the isolates from chicken feces, S. aureus 
C3 was resistant to as many as eight different antibiotics; they are SXT25, PEF5, CIP5, E15, 
CN10, K30, S10, and NA30 and S. aureus C5 was observed to be resistant to PEF5, and CIP5. 
Other S. aureus isolates from chicken feces showed resistance to none of the antibiotics (Figure 
17).  Among the isolates from human sewage sample, S. aureus H3 was resistant to NA30. S. 
aureus H5 showed resistance to four different antibiotics, which are E15, CN10, NA30, and 
F300. S. aureus H8 was observed to be resistant to CN10, and CXM30. Other S. aureus isolates 
collected from human sewage sample showed resistance to none of the test antibiotics (Figure 
18). Result of this study shows that these organisms have been well exposed to the tested 
antimicrobials and they have developed mechanisms to avoid them. 
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Similar studies were done in various parts of the world to know the resistance pattern of 
different microorganisms. As example, it is well established that methicillin resistant 
Staphylococcus aureus (MRSA) has been a major challenge for the last 30 years, and in 1993, a 
study had examined S. aureus isolates from 9 different hospitals and found that 15% of isolates 
were resistant to methicillin [13]. Whereas, in this study S. aureus isolated from environmental 
sample (chicken feces) were found to be resistant to as many as eight different antibiotics, which 
are SXT25, PEF5, CIP5, E15, CN10, K30, S10, and NA30. This is a drastic change brought on 
by evolution. 
Likewise, in Ireland, data that has been collected since 1996 had found high levels of 
resistance among Salmonella enterica serotype Typhimurium. Many isolates had been found to 
be resistant to at least 5 antibiotics, Ampicillin, Chloramphenicol, Streptomycin, Sulphonamide 
and tetracycline (ACSSuT). In this study S. typhi isolated from human sewage sample was 
observed to be resistant to three to four different antibiotics [14]. Among them are FOX30, E15, 
S10, SXT25, PEF5, and C30. This data only supports the fact that organisms are evolving in 
every possible ways and are gaining resistance to different and newer antibiotics. In this past 
decade, various key organizations, including the Infectious Diseases Society of America, the 
Centers for Disease Control and Prevention, and the World Health Organization (WHO), have 
made antibiotic resistance the focus of highly visible reports, conferences, and actions [15]. 
Genetic variability is essential for survival and antimicrobial agents will favor those 
organisms capable of resisting them. Microorganisms are either inherently resistant, that is, 
resistance determined by the basic nature of the organism or they can develop acquired 
resistance, which is the resistance that develops in a previously sensitive strain. Acquired 
resistance has generally been found to be derived from the use of antimicrobials. In addition, 
resistance problems are greatest in countries with highest use and in areas where use is 
concentrated, like intensive therapy units [9]. 
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Antimicrobial resistance pattern monitoring will help us to review the current status of 
antimicrobial resistance locally, nationally and globally and helpful in minimizing the 
consequence of drug resistance, limit the emergence and spread of drug resistant pathogens. This 
has been a major endeavor of this study. Resistance to antibiotic is increasing and significant 
community health problems are at risk. An accelerated start up of developing new antibiotics and 
taking measures to conserve the existing microbial agents can be our way to alleviate the current 
problem. Also the widespread usage of antibiotics should be brought to a controlled manner 
along with the measures to help control the bacterial spread to slow the emergence and spread of 
resistant organisms.  
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Chapter 5: Conclusion 
Undoubtedly, we are living in the wonder years of modern medical sciences and enjoying a 
longer and healthier life. Antibiotics are one of the major reasons behind this, as it has been our 
vital source in fighting against various infectious diseases. Since the very beginning of 
antibiotics starting with the discovery of Penicillin, a diverse range of antibiotics have aided us 
persistently in our battle against the diseases.  
It is alarming that despite all these advances in medical science and development of new 
antibiotics, the rate of morbidity and mortality due to antibiotic resistant pathogens are 
increasing. One of many reasons behind this is the widespread antibiotic usage, as it drives the 
pathogens to develop resistance. Now it is crucial to access the resistance pattern of pathogenic 
organisms to come up with a solution. This present study has been done in reflection to this fact, 
and the conclusion can be drawn that this comparative analysis will take us one step closer to 
resolving this global problem. 
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Appendices 
APPENDIX-I 
Media composition 
The composition of the media used in the present study has been given below. Unless 
otherwise mentioned, all the media were autoclaved at 121
o
C for 15 min.  
 
1. Nutrient Agar (Himedia,India) 
 
Ingredients Amounts (g/L) 
Peptic digest of animal tissue 5.0 
Beef extract 1.50 
Sodium chloride 5.0 
Yeast extract 1.50 
Agar 15.0  
 
2. Nutrient Broth (Oxoid, England) 
 
Ingredients Amount (g/L) 
Lab-lemco powder 1.0 
Yeast extract 2.0 
Peptone 5.0 
Sodium chloride 5.0 
 Appendices Page II 
 
3. Cetrimide agar (Merck, India) 
 
Ingredients Amount (g/L) 
Pancreatic digest of gelatin 20.0 
Magnesium chloride hexahydrate 1.4 
Potassium sulfate anhydrous 10.0 
Cetrimide 0.3 
Agar-Agar 13.0 
 
 
4. T1N1 soft agar 
 
Ingredients Amount (g/L) 
Tryptone 0.6 g 
Sodium chloride 0.3g 
Agar 0.42 g 
 
5. Tryptone soy broth, (Oxoid, England)  
 
Ingredients Amount (g/L) 
Pancreatic digest of Casein  17.0 
Papaic digest of soybean meal 3.0 
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Sodium chloride 5.0 
Di-basic potassium phosphate 2.5 
Glucose 2.5 
 
6. MacConkey agar (Oxoid, England) 
 
Ingredients Amount (g/L) 
Peptone 20.0 
Lactose 10.0 
Bile salts 5.0 
Sodium chloride 5.0 
Neutral red 0.075 
Agar 12.0 
 
 
7. Simmon’s citrate agar (Oxoid, England) 
 
Ingredients Amount (g/L) 
Magnesium sulfate 0.2 
Ammonium dihydrogen phosphate 0.2  
Ammonium phosphate 0.8 
Sodium citrate 2.0 
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Sodium chloride 5.0 
Agar 15.0 
Bacto brom thymol blue 0.08 
 
8. Peptone Water  
 
Ingredients Amount (g/L) 
Peptone 10.0  
Sodium chloride 5.0 
 
 
9. MR-VP broth  
 
Ingredients Amount (g/L) 
Peptone 7 g 
Dextrose 5 g 
Potassium phosphate 5 g 
 
10. Triple sugar iron agar (Himedia, India) 
 
Ingredients Amount (g/L) 
Peptic digest of animal tissue 10.0 
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Sodium chloride 5.0 
Lactose 10.0 
Sucrose 10.0 
Dextrose 1.0 
Ferrous sulfate 0.20 
Sodium thiosulfate 0.30 
Casein enzymatic hydrolysate 10.0 
Yeast extract 3.0 
Beef extract 3.0 
 
 
11. Eosine methylene blue agar (Oxoid, England) 
 
Ingredients Amount (g/L) 
Peptone 10.0 
Sucrose 5.0 
Lactose 5.0 
Di-potassium phosphate 2.0 
Eosin Y 0.14 
Methylene blue 0.065 
Agar 13.50 
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12. Mannitol Salt agar (Oxoid, England) 
 
Ingredients Amount (g/L) 
Peptone 10.0 
Manitol 10.0 
Lab-lemco powder 1.0 
Sodium chloride 75.0 
Phenol red 0.025 
Agar 15.0 
 
13. Thiosulfate Citrate Bile Salts Sucrose agar (Difco, USA) 
 
 
Ingredients Amount (g/L) 
Proteose peptone 10.0 
Sodium thiosulfate 10.0 
Sodium citrate 10.0 
Yeast extract 5.0 
Oxgall 8.0 
Sucrose 20.0 
Sodium chloride 10.0 
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Ferric citrate 1.0 
Bromothymol blue 0.04 
Thymol blue 0.04 
Agar 15.0 
 
14. Xylose Lysine Deoxycholate agar (Himedia, India) 
 
Ingredients Amount (g/L) 
L- lysine 5.0 
Lactose 7.50 
Sucrose 7.50 
Xylose 3.50 
Sodium chloride 5.0 
Sodium deoxycholate 2.50 
Yeast extract 3.0 
 
15. Phenol red (Lactose, Dextrose, Sucrose) Broth  
 
Ingredients Amount (g/L) 
Trypticase 0.4 
Lactose 0.2 
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Sucrose 0.2 
Dextrose 0.2 
Sodium chloride 0.2 
Phenol red 0.00072 
Final pH 7.3 
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APPENDIX-II 
 
Buffers and reagents 
 
1. Phosphate buffered saline (PBS) 
PBS was prepared by dissolving 8.0 g of NaCl, 0.2 g of KCl, 1.44 g of Na2HPO4 and 
2.0 g of KH2PO4 in 800 ml of distilled water. The pH was adjusted to 7.4 with HCl. 
The final volume was adjusted to 1 liter by distilled water. The solution was sterilized 
by autoclaving and was stored at room temperature. 
       
2. Kovac’s reagent 
5 g of para-dimethylaminobenzaldehyde was dissolved in 75 ml of amyl alcohol. 
Then concentrated HCl was added to make the final volume 25 ml. This reagent was 
covered with aluminum foil and stored at 4
o
C. 
 
3. Methyl red reagent 
0.1 g of methyl red was dissolved in 300 ml of 95% ethyl alcohol. Then distilled 
water was added to make the final volume 500 ml. This reagent was covered with 
aluminum foil and stored at 4
o
C. 
 
4. Barritt’s reagent 
 
Solution A 
5 g of alpha-naphthol was dissolved in 95% ethanol. This solution was covered with 
aluminum foil and stored at 4
o
C. 
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Solution B 
40 g of KOH was dissolved in distilled water. The solution became warm. After 
cooling to room temperature, creatine was dissolved by stirring. Distilled water was 
added. This solution was covered with aluminum foil and stored at  
 
5. Oxidase reagent 
100 mg of N,N,N
1
,N
1
-tetramethyl-p-phenyldiamine-dihydrochloride was dissolved in 
10 ml of distilled water and covered with aluminum foil. Then the solution was stored 
at 4
o
C. 
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APPENDIX-III 
 
Instruments 
 
The important equipments used through the study are listed below: 
 
  Autoclave SAARC 
  Freeze (-20°C) Siemens 
  Incubator SAARC 
  Micropipette (10-100µl) Eppendorf, Germany 
  Micropipette (20-200µl) Eppendorf, Germany 
  Oven, Model:MH6548SR LG, China 
  pH meter, Model: E-201-C Shanghai Ruosuaa 
Technology company, 
China 
  Refrigerator (4oC), Model: 0636 Samsung 
  
 
Safety cabinet 
Class II Microbiological 
SAARC 
  Shaking Incubator, Model: WIS-20R Daihan Scientific, Korea 
  Vortex Mixture VWR International 
  Water bath Korea 
 
  Weighing balance ADAM 
EQUIPMENT™, 
United Kingdom 
 
